Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pediatric placebo-controlled trials

Executive Summary

Pediatric subcommittee of the Anti-Infective Drugs Advisory Committee will meet Sept. 11 to discuss ethical considerations in the conduct of placebo-controlled clinical trials in the pediatric population. The subcommittee will also consider the development of psychotropic drugs for use in young children (1"The Pink Sheet" March 27, p. 26). The meeting will begin at 8 a.m. at the Hyatt Regency in Bethesda, Md

You may also be interested in...

FDA Pediatric Therapeutics Office To Consider Ethics, Postmarket Safety

FDA is in the process of hiring an epidemiologist to coordinate epidemiology and safety reviews of approved pediatric products within the newly created Office of Pediatric Therapeutics

FDA Pediatric Cmte. To Discuss Psychotropic Drug Protocols For Preschoolers

FDA's Pediatric Advisory Subcommittee is expected to discuss appropriate study designs for testing the use of psychotropic drugs in a preschool population at its September meeting.

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts